Varian Eclipse Software Users Take Top Spots in Treatment Plan Study
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Jefferies Raises Price Target on Varian Medical Systems (VAR) to $98; Reiterates Buy
July 28, 2016 9:21 AM EDTJefferies reiterated a Buy rating on Varian Medical Systems (NYSE: VAR), and raised the price target to $98.00 (from $95.00), following the company's 3Q report.
Analyst Anthony Petrone commented, "VAR put up a $9mn/$0.05 beat highlighted by a surge in NA Oncology orders to +15% (from +7%).... More
